Long Term Safety of Anifrolumab in Adult Subjects With Active Systemic Lupus Erythematosus
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Raj Tummala, MD
AstraZeneca
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
175 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
Mendoza, Argentina
- Research Site
Quilmes, Argentina
- Research Site
San Miguel de Tucumán, Argentina
- Research Site
Fitzroy, Australia
- Research Site
Kogarah, Australia
- Research Site
Plovdiv, Bulgaria
- Research Site
Plovdiv, Bulgaria
- Research Site
Hamilton, Ontario, Canada
- Research Site
Rimouski, Quebec, Canada
- Research Site
Osorno, Chile
- Research Site
Santiago, Chile
- Research Site
Viña del Mar, Chile
- Research Site
Armenia, Colombia
- Research Site
Barranquilla, Colombia
- Research Site
Medellín, Colombia
- Research Site
Bordeaux, France
- Research Site
Lille, France
- Research Site
Montpellier, France
- Research Site
Paris, France
- Research Site
Paris, France
- Research Site
Pessac, France
- Research Site
Berlin, Germany
- Research Site
Frankfurt am Main, Germany
- Research Site
Hamburg, Germany
- Research Site
Jena, Germany
- Research Site
Kirchheim, Germany
- Research Site
Mainz Am Rhein, Germany
- Research Site
Budapest, Hungary
- Research Site
Debrecen, Hungary
- Research Site
Szeged, Hungary
- Research Site
Zalaegerszeg, Hungary
- Research Site
Haifa, Israel
- Research Site
Haifa, Israel
- Research Site
Jerusalem, Israel
- Research Site
Kfar Saba, Israel
- Research Site
Tel Aviv, Israel
- Research Site
Chiba, Japan
- Research Site
Chūōku, Japan
- Research Site
Fukuoka, Japan
- Research Site
Fukuoka, Japan
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2016
- Primary completion
- 21 Dec 2021
- Completion
- 21 Dec 2021
- Last update posted
- 13 Jan 2023
- Registered enrollment
- 559
- Registry id
- NCT02794285
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.